查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1627915

輸液袋市場：未來預測（2025-2030）

IV Bags Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 141 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

輸液袋市場預計將從 2025 年的 43.12 億美元成長到 2030 年的 56.77 億美元，複合年成長率為 5.66%。

靜脈注射袋是一種裝有液體、電解質、維生素、礦物質、葡萄糖溶液等的袋子，用於輸送身體所需的液體和營養素。輸液包的需求是由電解質耗盡、補水不足和營養不良等問題日益嚴重所驅動，這推動了對注入人體的液體營養素和替代品的需求。

此外，由於輸液袋易於獲取，正逐漸成為一種流行且優選的腸外給藥替代品。一個輸液包的成本約為1美元，這對市場貿易的擴張做出了巨大貢獻。

此外，道路交通事故是全球造成殘疾和死亡的主要原因之一，每年導致 5,000 萬人受傷和 130 萬人死亡。根據世界衛生組織 (WHO) 的數據，全球整體四分之一的死亡與步行或騎自行車有關。因此，手術和事故的增加將需要輸液，預計這將刺激市場擴張。

輸液袋市場促進因素

  • 慢性病的流行正在推動市場需求。

在預計預測期內，慢性病盛行率上升、手術和道路事故數量增加以及老年人口成長等因素將推動市場成長。例如，美國國立衛生研究院2022年7月表示，在北美和歐洲等西方地區，截至2022年，約有20%的個體患有胃食道逆流（GERD）。此外，美國GERD 的發生率從 18.1% 上升至 27.8%。

此外，《2023 年癌症現實與數據》報告的資訊預測，2023 年美國將有 297,790 名女性死於乳癌，高於 2022 年的 287,850 例。此外，根據同一資訊來源，預計 2023 年美國約有 55,720 名女性被診斷出患有非侵入性（原位）乳癌，而 2022 年這一數字為 51,400 例。由於癌症治療會對身體造成影響，剝奪身體的營養，並導致潰瘍、胃腸功能障礙和身體阻塞，因此對輸液袋的需求預計會增加。接受腸外營養的患者的需求不斷成長，推動了市場擴張。

輸液袋市場的地理前景

  • 預計在預測期內北美仍將是市場的主要股東。

從地理上看，輸液袋市場分為北美洲、南美洲、歐洲、中東和非洲以及亞太地區。

在預測期內，預計北美將佔據相當大的市場佔有率，這得益於主要區域經濟體慢性病患病率的上升、醫療保健基礎設施的完善以及外科手術和醫院就診數量的增加。美國醫院協會稱，2022年，美國住院人數達34,011,386人次，而醫院住院人數為6,129人次。

同樣，外科手術的流行也推動了市場需求。例如，根據美國整形外科醫師協會的數據，2023 年報告的手術總數為 1,575,244 例，比 2022 年報告的數字增加了 5%。此外，亞伯達省政府提供的資料顯示，2022年手術總數為292,500次，比前一年增加了13,900次。

為什麼要購買這份報告？

  • 深刻分析：獲得深入的市場洞察，涵蓋主要地區和新興地區，重點關注客戶群、政府政策和社會經濟因素、消費者偏好、垂直行業和其他子區隔。
  • 競爭格局：了解全球主要企業所採用的策略策略，並了解正確策略帶來的潛在市場滲透率。
  • 市場促進因素和未來趨勢：探索動態因素和關鍵市場趨勢以及它們將如何影響市場的未來發展。
  • 可行的建議：利用洞察力進行策略決策，在動態環境中開闢新的業務流和收益。
  • 適合廣泛的用戶：對於新興企業、研究機構、顧問公司、中小企業和大型企業來說，它都是實用且具有成本效益的。

它有什麼用途？

產業與市場洞察、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本支出決策、法律規範與影響、新產品開發、競爭影響

分析範圍

  • 歷史資料與預測（2022-2030）
  • 成長機會、挑戰、供應鏈前景、法規結構、顧客行為、趨勢分析
  • 競爭對手定位、策略與市場佔有率分析
  • 按部門和地區（國家）分類的收益成長和預測分析
  • 公司簡介（策略、產品、財務資訊、主要趨勢等）

輸液袋市場細分為：

按類型

  • PVC
  • PP
  • PE

按容量

  • 少於100毫升
  • 100～250ml
  • 250～500ml
  • 500～1000ml
  • 1000毫升以上

按腔室類型

  • 單室
  • 多室

按最終用戶

  • 血庫
  • 醫院
  • 門診服務

按地區

  • 北美洲
  • 美國
  • 加拿大
  • 墨西哥
  • 南美洲
  • 巴西
  • 阿根廷
  • 其他
  • 歐洲
  • 德國
  • 法國
  • 英國
  • 西班牙
  • 其他
  • 中東和非洲
  • 沙烏地阿拉伯
  • 以色列
  • 其他
  • 亞太地區
  • 中國
  • 日本
  • 韓國
  • 印度
  • 其他

目錄

第 1 章 簡介

  • 市場概況
  • 市場定義
  • 分析範圍
  • 市場區隔
  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關利益者的主要利益

第 2 章 分析方法

  • 分析設計
  • 分析過程

第3章執行摘要

  • 主要發現
  • CXO觀點

第4章 市場動態

  • 市場促進因素
  • 市場限制
  • 波特五力分析
  • 產業價值鏈分析
  • 分析師觀點

第5章 輸液袋市場類型

  • 介紹
  • PVC
  • PP
  • PE

第6章 輸液袋市場規模

  • 介紹
  • 少於100毫升
  • 100～250ml
  • 250～500ml
  • 500～1000ml
  • 1000毫升以上

第7章 輸液袋市場（依腔室類型）

  • 介紹
  • 單室
  • 多室

第 8 章 輸液袋市場以最終用戶分類

  • 介紹
  • 血庫
  • 醫院
  • 門診服務

第9章 輸液袋市場區域分佈

  • 介紹
  • 北美洲
    • 按類型
    • 按容量
    • 按腔室類型
    • 按最終用戶
    • 按國家
  • 南美洲
    • 按類型
    • 按容量
    • 按腔室類型
    • 按最終用戶
    • 按國家
  • 歐洲
    • 按類型
    • 按容量
    • 按腔室類型
    • 按最終用戶
    • 按國家
  • 中東和非洲
    • 按類型
    • 按容量
    • 按腔室類型
    • 按最終用戶
    • 按國家
  • 亞太地區
    • 按類型
    • 按容量
    • 按腔室類型
    • 按最終用戶
    • 按國家

第10章 競爭格局及分析

  • 主要企業和策略分析
  • 市場佔有率分析
  • 企業合併（M&A）、協議、商業合作
  • 競爭儀錶板

第11章 公司簡介

  • Sippex
  • Kraton Corporation
  • Renolit Solmed
  • Alfa Laboratories
  • Polycine GmbH
  • Haemotronic SPA
  • Hospira Inc.
  • Technoflex SA
  • The Metrix Company
  • Medicopack A/S
  • Wipak Group
  • Qosina Corporation
簡介目錄
Product Code: KSI061612706

The IV Bags market is projected to grow from US$4.312 billion in 2025 to US$5.677 billion in 2030 at a CAGR of 5.66%.

IV bags are pouches containing fluids, electrolytes, vitamins, minerals, and glucose solutions among others which are used in administering necessary fluids and nutrients in the body. The demand for IV packs is witnessing positive growth fueled by the growing electrolyte depletion, lack of hydration, and malnutrition problems in individuals which has bolstered the need for liquid nutrients and alternatives to be injected into the human body.

Furthermore, IV packs are becoming progressively prevalent and favored alternatives for parenteral bundling due to their simple accessibility. The cost of an IV sack is roughly $1, which significantly contributes to the market's rising deals.

Moreover, car crashes are one of the leading causes of disability and death worldwide, resulting in up to 50 million injuries and 1.3 million fatalities annually. Across the globe, one in every four deaths is related to walking or bicycling, based on the World Health Organization. Fluid administration is therefore required due to the rising number of surgeries and accidents, which is anticipated to spur market expansion.

IV Bags Market Drivers

  • Growing chronic disease prevalence is propelling the market demand.

Factors such as the rising prevalence of chronic diseases, the increased number of surgeries and road accidents, and the growing geriatric population are expected to drive market growth during the forecast period. For instance, according to the National Institute of Health in July 2022 stated that around 20% of individuals in western locales, such as North America and Europe, have gastroesophageal reflux illness (GERD) as of 2022. Besides, the predominance of GERD in the US extended from 18.1% to 27.8%

Furthermore, information from the Cancer Realities and Figures 2023 report demonstrates that 297,790 ladies in the US are expected to get an obtrusive breast cancer conclusion in 2023, up from 287,850 modern cases in 2022. Additionally, the same source states that in 2023, compared to 51,400 cases in 2022, approximately 55,720 women in the US are anticipated to receive a non-invasive (in situ) breast cancer diagnosis. Since cancer treatment deprives the body of nutrition and affects the body by causing ulcers, gastrointestinal dysfunction, and physical blockages, it is anticipated that the demand for IV bags will increase. It increases the need for patients to receive parenteral nutrition, which drives market expansion.

IV Bags Market geographical outlook

  • North America will continue to be the dominant market shareholder during the forecast period.

Geographically, the IV bags market has been segmented into North America, South America, Europe, the Middle East, Africa, and the Asia Pacific.

During the forecast period, the North American region is estimated to hold a considerable market share fueled by the growing chronic disease prevalence in the major regional economies, followed by well-established healthcare infrastructure and an increase in the number of surgical procedures and hospital visits. According to the American Hospital Association, in 2022, the strength of hospitals in the United States stood at 6,129, whereas the total number of admissions in U.S. hospitals reached 34,011,386.

Likewise, the increase in the prevalence of surgical procedures has also propelled the market demand, for instance, according to the American Society of Plastic Surgeons, in 2023, the total number of surgical procedures reported was 1,575,244 which signified a 5% growth over figure reported in 2022. Additionally, as per the data provided by the Alberta government, in 2022, the total number of surgeries conducted stood at 292,500 which represented a 13,900 increase over the preceding year's surgical volume.

Reasons for buying this report:-

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, other sub- segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape up future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decision to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data & forecasts from 2022 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, Customer Behaviour, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

The IV Bags Market is analyzed into the following segments:

By Type

  • PVC
  • PP
  • PE

By Capacity

  • Less than 100 ml
  • 100-250 ml
  • 250-500 ml
  • 500-1000 ml
  • Above 1000 ml

By Chamber Type

  • Single Chamber
  • Multi-Chamber

By End-User

  • Blood Banks
  • Hospitals
  • Ambulatory Services

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • Israel
  • Others
  • Asia Pacific
  • China
  • Japan
  • South Korea
  • India
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key Benefits to the Stakeholder

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Processes

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings
  • 3.2. CXO Perspective

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. IV BAGS MARKET BY TYPE

  • 5.1. Introduction
  • 5.2. PVC
  • 5.3. PP
  • 5.4. PE

6. IV BAGS MARKET BY CAPACITY

  • 6.1. Introduction
  • 6.2. Less than 100 ml
  • 6.3. 100-250 ml
  • 6.4. 250-500 ml
  • 6.5. 500-1000 ml
  • 6.6. Above 1000 ml

7. IV BAGS MARKET BY CHAMBER TYPE

  • 7.1. Introduction
  • 7.2. Single Chamber
  • 7.3. Multi-Chamber

8. IV BAGS MARKET END-USER

  • 8.1. Introduction
  • 8.2. Blood Banks
  • 8.3. Hospitals
  • 8.4. Ambulatory Services

9. IV BAGS MARKET BY GEOGRAPHY

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. By Type
    • 9.2.2. By Capacity
    • 9.2.3. By Chamber Type
    • 9.2.4. By End-User
    • 9.2.5. By Country
      • 9.2.5.1. USA
      • 9.2.5.2. Canada
      • 9.2.5.3. Mexico
  • 9.3. South America
    • 9.3.1. By Type
    • 9.3.2. By Capacity
    • 9.3.3. By Chamber Type
    • 9.3.4. By End-User
    • 9.3.5. By Country
      • 9.3.5.1. Brazil
      • 9.3.5.2. Argentina
      • 9.3.5.3. Others
  • 9.4. Europe
    • 9.4.1. By Type
    • 9.4.2. By Capacity
    • 9.4.3. By Chamber Type
    • 9.4.4. By End-User
    • 9.4.5. By Country
      • 9.4.5.1. Germany
      • 9.4.5.2. France
      • 9.4.5.3. United Kingdom
      • 9.4.5.4. Spain
      • 9.4.5.5. Others
  • 9.5. Middle East and Africa
    • 9.5.1. By Type
    • 9.5.2. By Capacity
    • 9.5.3. By Chamber Type
    • 9.5.4. By End-User
    • 9.5.5. By Country
      • 9.5.5.1. Saudi Arabia
      • 9.5.5.2. Israel
      • 9.5.5.3. Others
  • 9.6. Asia Pacific
    • 9.6.1. By Type
    • 9.6.2. By Capacity
    • 9.6.3. By Chamber Type
    • 9.6.4. By End-User
    • 9.6.5. By Country
      • 9.6.5.1. China
      • 9.6.5.2. Japan
      • 9.6.5.3. South Korea
      • 9.6.5.4. India
      • 9.6.5.5. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 10.1. Major Players and Strategy Analysis
  • 10.2. Market Share Analysis
  • 10.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 10.4. Competitive Dashboard

11. COMPANY PROFILES

  • 11.1. Sippex
  • 11.2. Kraton Corporation
  • 11.3. Renolit Solmed
  • 11.4. Alfa Laboratories
  • 11.5. Polycine GmbH
  • 11.6. Haemotronic S.P.A.
  • 11.7. Hospira Inc.
  • 11.8. Technoflex S.A.
  • 11.9. The Metrix Company
  • 11.10. Medicopack A/S
  • 11.11. Wipak Group
  • 11.12. Qosina Corporation